Trader: Low Volume ...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$0.52 -0.07 | -11.86%
06/04/12 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.59 |
| 52 Week High | 1.60 |
| 52 Week Low | 0.36 |
| Avg. Daily Vol. (Mil) | 0.20 |
| Beta (3 year) | 1.15 |
| Share Related Items | |
| Mkt Cap (Mil) | 34.81 |
| Shares Out (Mil) | 59.00 |
| Float (Mil) | 56.80 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.50 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 52.11 |
| Price/Book | 1.88 |
| Price/Cash Flow | -2.50 |
| Per Share Data | |
| Earnings | -0.28 |
| Sales | 0.01 |
| Book Value | 0.31 |
| Cash Flow | -0.24 |
| Business Summary | |
|---|---|
| Cyclacel Pharmaceuticals, Inc. is a development stage biopharmaceutical Company, dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. | |
| General Information | |
| 200 Connell Drive
Suite 1500 Berkeley Heights, NJ 07922 |
|
| www.cyclacel.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 18 | |
| CEO: Spiro Rombotis | |
| Short Interest | |
| Current Month (Mil) | 0.12 |
| Previous Month (Mil) | 0.15 |
| Short Interest Ratio (Days) | 0.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -53.70 |
| Return on Investments | -73.00 |
| Profitability | |
| Gross Margin | 73.40 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with CYCC
- Portfolio NameUser Type
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
- Contributor10 Biotech Stocks Expected ...
- UserJSD Holdings
- UserBesV Portfolio 1
- UserStock2009
- UserTdawg
Latest CYCC Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 03.02.12 | 01:03 pm
- Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex's Crash 03.02.12 | 05:03 am
- BIO CEO Conference Live Blog 02.13.12 | 01:02 pm
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling 11.16.11 | 08:11 am
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks 09.30.11 | 05:09 am
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- Cyclacel Stock Gaps Down On Today's Open (CYCC) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
Press Releases for CYCC
Partner Headlines for CYCC
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
- Cyclacel Pharmaceuticals Files S-3 $75M Mixed Securities Shelf - Benzinga 04.04.11 | 04:04 pm
- US scientists recreate heart defect in a lab dish - Reuters 02.09.11 | 01:02 pm
- Pfizer, Adolor End Collaboration to Develop Pain Meds: Biotech's Latest Troubles - Seeking Alpha 12.26.10 | 01:12 am
